Atlas Trials

Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer

Clinical trial NCT06357598 · UNKNOWN

Trial details

NCT number
NCT06357598
Sponsor
The Affiliated Hospital of Qingdao University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Non-small-cell Lung Cancer (NSCLC)
Start date
2024-01-18
Primary completion
2024-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.